COMMUNIQUÉS West-GlobeNewswire

Valneva to Participate at U.S. and European Investor Conferences in June
28/05/2026
Lyon (France), May 28, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor [...]
Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance
28/05/2026
CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers Watch the “What This Means” video here TAMPA, Fla. and LONDON, May 28, 2026 (GLOBE NEWSWIRE [...]
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
28/05/2026
Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- A new survey from Progyny (Nasdaq: PGNY), a global [...]
Clue Becomes the First Insurance-Covered Period and Menstrual Cycle Tracker in the World
28/05/2026
BERLIN, May 28, 2026 (GLOBE NEWSWIRE) -- Clue , the #1 women-led period and cycle tracker, today announced a partnership with Süddeutsche Krankenversicherung a. G. (SDK), one of Germany’s leading private health insurers [...]
Serotonin Centers Opens in Lake Nona, Expanding Physician-Led Longevity Care into One of the Nation’s Leading Health Innovation Communities
28/05/2026
New Location Aligns with Growing Demand for Data-Driven Wellness, Hormone Optimization and Advanced Recovery Therapies ORLANDO, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science- [...]
Fortis Life Sciences Expands AbNano® Portfolio with First VHH Library Derived from Peripheral Natural Killer Cells for Rapid Antibody Discovery
28/05/2026
The new AbNano® library enables VHH discovery against complex NK-cell-associated targets for engineered cell platforms and translational research BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Fortis Life Sciences today [...]
MMI Earns Gold Edison Award for Symani®, Recognized for Expanding Access to Life-Changing Surgical Treatment Options
28/05/2026
Symani honored for advancing lymphatic microsurgery – from treating lymphedema to enabling exploration of new disease pathways JACKSONVILLE, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a [...]
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Circular Genomics for the Transformative Bio-Hermes-001 Study
28/05/2026
Collaboration to accelerate the investigation of Alzheimer’s disease biomarkers with early access to Bio-Hermes-001 data WASHINGTON, May 28, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation ® (GAP) is [...]
ProMIS Neurosciences to Participate in Upcoming Conferences in June
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in [...]
MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
28/05/2026
First patient dosed marks rapid transition from trial activation to active treatment in patients with acute lung injury from all cause pneumonia meeting Global ARDS criteria Landmark advances a first-in-class immune [...]
Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026
28/05/2026
“Best of EASL” oral presentation highlights meaningful reductions in triglycerides, cholesterol, and blood pressure, along with improvements in key metabolic risk factors PERFORMA Phase 3 trial to further evaluate the [...]
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
28/05/2026
NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA), a clinical [...]
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
MENLO PARK, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment [...]
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
28/05/2026
As of May 27, 2026, Enlivex held 79,568,550,005 RAIN tokens with a total value of approximately $1.16 billion. Separately, the Rain Foundation recently announced the appointment of five industry leaders to its advisory [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
28/05/2026
ZUG, Switzerland and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team are scheduled to participate in the following investor [...]
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
28/05/2026
Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) until 2044 Sol-Gel completed an oversubscribed underwritten offering, raising [...]
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
28/05/2026
Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time). The Board of Directors recommends shareholders vote FOR all director nominees and resolutions, before the 11:00 a [...]
Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
28/05/2026
VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
World Trade Center Health Program Launches National Awareness Initiative to Reach Those Who Were Impacted by 9/11 as Children or Teens
28/05/2026
New outreach initiative features New York City sketch artist and influencer Devon Rodriguez to reach individuals impacted by 9/11 at an early age and help them understand they may be eligible for no-cost medical [...]

Pages